The Healthcare Technology Report

Automating Healthcare Operations: Medallion’s Derek Lo with RJ Lumba Every day, providers lose weeks waiting on credentialing, licensing, and enrollment. Medallion compresses that into days. Its platform automates the operational workflows behind healthcare delivery—work that once consumed full teams and mountains of paperwork. Derek Lo, who built and sold his first startup before age 25, launched Medallion in 2020 to turn that bottleneck into a growth lever. Since then, the company has saved over 500,000 hours of administrative work for hundreds of organizations, from digital health pioneers to major hospital systems, while cutting operating costs in half. With $130 million raised including a fresh $43 million round led by Acrew Capital, Medallion is scaling the infrastructure that lets healthcare organizations expand faster, see patients sooner, and focus on care over compliance. Listen on iTunes: https://lnkd.in/gVF9bCbh Listen on YouTube: https://lnkd.in/gDiETrKY Listen on Spotify: https://lnkd.in/gQj9Tr8U Visit our website: https://lnkd.in/g2uauKPr To nominate for Top Healthcare Technology CEOs of 2025, click here: https://lnkd.in/d9crSvH Sign up for our free email newsletter at https://lnkd.in/gNfBS6g #Entrepreneur #Podcast #HealthTech #Healthcare #HealthcareAutomation #HealthcareTransformation

Arena BioWorks Names Harvey Berger as CEO to Accelerate Drug Discovery To nominate for Top 100 Healthcare Technology Companies of 2025, click here: https://lnkd.in/g_SjH_kp Sign up for our free email newsletter at https://lnkd.in/gNfBS6g #healthtech #healthcare #biotechnology #research #leadership https://lnkd.in/eTW4Qu4T

Backed By Larry Ellison, Imagene AI Is Making Precision Oncology More Precise Precision oncology just got more precise. Tel Aviv-based Imagene AI has teamed up with Sheba Medical Center to merge Sheba’s extensive patient datasets, including digitized pathology slides, genomic information, and longitudinal clinical records, with Imagene AI’s Cross-Modality Intelligence Engine. And that’s just the beginning. In July, the company raised $25 billion in Series B funding led by none other than Oracle Chief Executive Officer and investing legend Larry Ellison to advance its multi-modal digital pathology foundation models for precision medicine. Founded in 2020 by CEO Dean Bitan, Jonathan Zalach and Shahar Porat, Imagene’s team is split between Israel and the United States – fitting for a company that’s solving problems that necessarily cross borders. It’s this type of focus that prompted one analyst to declare Imagene was ready to “dominate” precision oncology as part of a “portfolio of the future.” Which means the company is living up to its mission to “help create a clearer and more personalized journey for patients and their loved ones, in cancer and beyond.” Back at Sheba Medical Center, where Imagene initially focused on lung cancer, the collaboration has expanded to a cross-cancer platform, enabling independent analysis of complex datasets and the development of predictive models across multiple cancer types. Professor Iris Barshack, Head of the Pathology Institute at Sheba, said that Imagene “empowers our pathologists and care teams to analyze multimodal data, independently develop AI applications, and move faster from hypothesis to validated signal.” But Sheba’s not the only medical center being empowered. Imagene AI’s data infrastructure already integrates more than 3.5 million digitized pathology slides alongside diverse omics and clinical data, which Bitan says is the key to bring “precision oncology closer to patients.” In both hemispheres.

High-Precision Cell Therapy: Orca Bio’s Nathaniel Fernhoff with RJ Lumba Every stem cell transplant today is a balancing act: cure the cancer, but risk life-threatening complications. Orca Bio believes patients shouldn’t have to make that tradeoff. CEO and Co-Founder Nathaniel Fernhoff and his team have developed a manufacturing platform that builds cell therapies at single-cell precision. Their investigational products, Orca-T and Orca-Q, aim to deliver the curative potential of transplants without the burden of chronic graft-versus-host disease and other complications. Following the completion of its pivotal trial, Orca Bio is preparing to bring its first therapy to regulators this year. Roughly 50,000 Americans are diagnosed annually with blood cancers that could benefit from a safer approach—and future applications in autoimmune disease could extend the impact to tens of thousands more. Precision is turning possibility into practice, and Orca Bio is setting the pace. Listen on iTunes: https://lnkd.in/gWJmb7Nc Listen on YouTube: https://lnkd.in/gtMwWmA3 Listen on Spotify: https://lnkd.in/gFMnpZbs Visit our website: https://lnkd.in/gpSfNx84 To nominate for Top Healthcare Technology CEOs of 2025, click here: https://lnkd.in/d9crSvH Sign up for our free email newsletter at https://lnkd.in/gNfBS6g #Entrepreneur #Podcast #HealthTech #BioTech #CellTherapy #Oncology

The Autonomous Pharmacy: Omnicell’s Randall Lipps with RJ Lumba Randall Lipps is the Founder, Chairman, President, and CEO of Omnicell, a global leader in medication management and pharmacy automation. Omnicell provides robotics, intelligent software, and data-driven services that help hospitals and pharmacies reduce errors, improve efficiency, and advance toward the vision of the Autonomous Pharmacy. Randall founded Omnicell in 1992 after experiencing firsthand the inefficiencies of supply management during his daughter’s hospitalization. Drawing on his background in airline operations and logistics, he set out to build solutions that would make it easier for caregivers to get the right medications to patients. Randall supports American Nurse Association. To learn more about this organization click here: https://lnkd.in/e55urY5 Listen on iTunes: https://lnkd.in/gfnPCWWd Listen on YouTube: https://lnkd.in/gMz4frfP Listen on Spotify: https://lnkd.in/gXMwukDh Visit our website: https://lnkd.in/gvFHYSyk To nominate for Top Healthcare Technology CEOs of 2025, click here: https://lnkd.in/d9crSvH Sign up for our free email newsletter at https://lnkd.in/gNfBS6g #healthtech #healthcare #leadership #pharmacy #software

Twin Health Raises $53M for AI-Driven Diabetes and Obesity Care To nominate for Top Healthcare Technology CEOs of 2025, click here: https://lnkd.in/d9crSvH Sign up for our free email newsletter at https://lnkd.in/gNfBS6g #healthtech #healthcare #hospitals #artificialintelligence https://lnkd.in/epCU2EsE

The Top 25 Healthcare Software Companies of 2025 The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Software Companies of 2025. Abridge set the pace with one of the largest healthcare AI funding rounds of the year, raising $300 million to expand its generative AI platform, with adoption spreading rapidly across leading health systems. Abridge, Qualifacts, PartsSource Inc., Komodo Health, Home Medical Management (HMM), Clearwave Corporation, TriNetX, Loftware, ScienceSoft USA Corporation, Phreesia, NextGen Healthcare, Epic Systems, H1, Kyruus Health, Relatient, Cedar, QGenda, Cohere Health, ELLKAY, Cedar Gate Technologies, Candid Health, Luma Health, Andros, Healthie, and Zus Health. To nominate for Top 100 Healthcare Technology Companies of 2025, click here: https://lnkd.in/g_SjH_kp Sign up for our free email newsletter at https://lnkd.in/gNfBS6g #healthtech #healthcare #software https://lnkd.in/eMPVGBWU

Epic Unveils Comet to Forecast Patient Trajectories and Guide Clinical Decisions To nominate for Top 100 Healthcare Technology Companies of 2025, click here: https://lnkd.in/g_SjH_kp Sign up for our free email newsletter at https://lnkd.in/gNfBS6g #healthtech #healthcare #software https://lnkd.in/ehMBrjhZ

Remedy Meds to Acquire Thirty Madison in $500M Deal To nominate for Top 100 Healthcare Technology Companies of 2025, click here: https://lnkd.in/g_SjH_kp Sign up for our free email newsletter at https://lnkd.in/gNfBS6g #healthtech #healthcare #retail #pharmacies #hospitals https://lnkd.in/eCBEnsfx

Galvanize Therapeutics receives $100 million in funding from Ally Bridge Group, ATP (Apple Tree Partners), Elevage Medical Technologies, Fidelity Investments, Gilmartin Capital LLC, Intuitive, Janus Henderson Investors, Longaeva Partners LP, Norwest Venture Partners, Perceptive Xontogeny Venture Fund, Sofinnova Partners, and T. Rowe Price. Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions. To nominate for Top 100 Healthcare Technology Companies of 2025, click here: https://lnkd.in/g_SjH_kp Sign up for our free email newsletter at https://lnkd.in/gNfBS6g #healthtech #healthcare #venturecapital #biomedical #therapeuticproducts